Ivan Cichowicz, MD
Geriatric Psychiatry · Boca Raton, FLNPI 1932312840
Payments from drug & device makers
Across 1,109 payments — averaging $704.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$465K
- Johnson & Johnson$186K
- Janssen Research & Development, LLC$59K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$11K
- Otsuka America Pharmaceutical, Inc.$2K
- plus $7K from 21 others
Across 13 payments — averaging $115.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 294 | $464,512 |
| Johnson & Johnson | 287 | $186,326 |
| Janssen Research & Development, LLC | 3 | $58,694 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 102 | $52,445 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $10,850 |
| Otsuka America Pharmaceutical, Inc. | 54 | $1,748 |
| Teva Pharmaceuticals USA, Inc. | 50 | $1,368 |
| Lundbeck LLC | 92 | $1,176 |
| AbbVie(2 entities) | 68 | $1,107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 70 | $1,030 |
| Alkermes, Inc. | 25 | $556 |
| Axsome Therapeutics, Inc. | 8 | $419 |
| Acadia Pharmaceuticals Inc | 4 | $246 |
| Neurocrine Biosciences, Inc. | 13 | $230 |
| Supernus Pharmaceuticals, Inc. | 5 | $181 |
| Idorsia Pharmaceuticals US Inc | 4 | $157 |
| E.r. Squibb & Sons, L.L.C. | 6 | $142 |
| Neuronetics, Inc. | 5 | $124 |
| Noven Pharmaceuticals, Inc. | 1 | $123 |
| Lilly USA, LLC | 2 | $118 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Almatica Pharma LLC | 4 | $72 |
| Noven Therapeutics, LLC | 2 | $44 |
| Avanir Pharmaceuticals, Inc. | 2 | $42 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $12 |
How this compares
$781,837 in reported general payments places this provider in the 90th percentile of 33 geriatric psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other geriatric psychiatry in Boca Raton
- Helia Ibarra-AlosBoca Raton$756
- Louis GoldBoca Raton$0
- Amanda SmithTampa$6.5M
- Nandita JoshiJacksonville$5.3M
- Mark HernandezHialeah$3.4M
- Maria ParicioSouth Miami$499K
- Vinod BhatnagarFort Myers$28K
- Julio MachadoMiami$8K
- Luis VinuelaMelbourne$7K
- Ramon PinoGainesville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.